✦ LIBER ✦

Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States

✍ Scribed by Lee, Soyon; Baxter, Daniel C.; Limone, Brendan; Roberts, Matthew S.; Coleman, Craig I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND8 COST-EFFECTIVENESS AND BUDGET IMPAC

✍ O Espallardo; C Crespo; C Polanco; D Nieves 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Cost-Effectiveness of Glatiramer Acetate

✍ Darba, J.; Kaskens, L.; Sánchez-de la, R.osa R 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Comparison of fingolimod with interferon

✍ Bhupendra Khatri; Frederik Barkhof; Giancarlo Comi; Hans-Peter Hartung; Ludwig K 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 228 KB

Cost-effectiveness of natalizumab versus

✍ O’Day, Ken; Meyer, Kellie; Miller, Ross M.; Agarwal, Sonalee; Franklin, Meg 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 373 KB

Cochrane Database of Systematic Reviews

✍ Zhang, Jian 📂 Article 📅 2014 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 295 KB

5-31-07 Interferon beta 1a in the treatm

✍ Ljapcev, R.; Gogovska, L.; Tanovska, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 180 KB